Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Paul Reynolds

Concepts (112)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
2
2020
599
1.080
Why?
Intensive Care Units
5
2020
531
1.040
Why?
Critical Illness
5
2019
481
0.890
Why?
Inappropriate Prescribing
1
2020
42
0.860
Why?
Beriberi
1
2019
3
0.840
Why?
Thiamine Deficiency
1
2019
4
0.840
Why?
Wernicke Encephalopathy
1
2019
3
0.840
Why?
Venous Thromboembolism
2
2019
171
0.830
Why?
Guillain-Barre Syndrome
1
2019
18
0.820
Why?
Peptic Ulcer
1
2018
15
0.810
Why?
Serotonin Syndrome
1
2018
8
0.790
Why?
Serotonin Agents
1
2018
11
0.790
Why?
Peripheral Nervous System Diseases
1
2019
91
0.790
Why?
Fluid Therapy
1
2020
138
0.790
Why?
Drug Hypersensitivity
1
2019
79
0.780
Why?
Fluoxetine
1
2018
45
0.760
Why?
Heparin
1
2019
208
0.730
Why?
Anticoagulants
2
2019
532
0.710
Why?
Pain Management
1
2020
304
0.690
Why?
Respiration, Artificial
2
2020
513
0.680
Why?
Cholestyramine Resin
1
2015
8
0.660
Why?
Drug Overdose
1
2018
203
0.640
Why?
Isoxazoles
1
2015
51
0.640
Why?
Glial Cell Line-Derived Neurotrophic Factor
1
2015
23
0.630
Why?
Nerve Growth Factor
1
2015
37
0.620
Why?
Sepsis
1
2020
418
0.610
Why?
Prosthesis-Related Infections
1
2015
75
0.610
Why?
Dexmedetomidine
1
2015
65
0.590
Why?
Extravasation of Diagnostic and Therapeutic Materials
1
2014
14
0.580
Why?
Shock, Septic
1
2015
137
0.580
Why?
Osmotic Pressure
1
2014
40
0.580
Why?
Epinephrine
1
2015
185
0.560
Why?
Brain-Derived Neurotrophic Factor
1
2015
166
0.550
Why?
Substance Withdrawal Syndrome
1
2015
173
0.540
Why?
Antirheumatic Agents
1
2015
247
0.540
Why?
Vasoconstriction
1
2014
198
0.520
Why?
Practice Patterns, Physicians'
1
2020
1117
0.470
Why?
Alcoholism
1
2015
766
0.390
Why?
Histamine H2 Antagonists
2
2018
21
0.350
Why?
Gastrointestinal Hemorrhage
2
2018
104
0.330
Why?
Proton Pump Inhibitors
2
2018
90
0.320
Why?
Retrospective Studies
6
2020
10064
0.270
Why?
Time Factors
4
2020
7066
0.260
Why?
Humans
15
2021
104249
0.240
Why?
Risk Factors
5
2019
8467
0.240
Why?
Invasive Fungal Infections
1
2021
11
0.240
Why?
Aspergillosis
1
2021
32
0.240
Why?
Cohort Studies
3
2020
4560
0.240
Why?
Candidiasis
1
2021
55
0.240
Why?
Therapeutic Index
1
2020
3
0.230
Why?
Thrombocytopenia
2
2019
169
0.220
Why?
Middle Aged
6
2020
27633
0.220
Why?
Factor Xa
1
2019
19
0.210
Why?
Female
10
2020
59707
0.210
Why?
Heparin, Low-Molecular-Weight
1
2018
32
0.200
Why?
Cyproheptadine
1
2018
9
0.200
Why?
Trazodone
1
2018
4
0.200
Why?
Serotonin Antagonists
1
2018
26
0.200
Why?
Risperidone
1
2018
27
0.200
Why?
Macrolides
1
2019
74
0.200
Why?
Serotonin Receptor Agonists
1
2018
31
0.200
Why?
Bupropion
1
2018
32
0.200
Why?
Factor Xa Inhibitors
1
2018
100
0.190
Why?
Hemorrhage
2
2019
526
0.190
Why?
Dopamine Uptake Inhibitors
1
2018
66
0.190
Why?
Benzodiazepines
1
2018
110
0.180
Why?
Male
9
2020
58392
0.180
Why?
Inpatients
1
2020
265
0.180
Why?
Venous Thrombosis
1
2019
129
0.180
Why?
Serotonin Uptake Inhibitors
1
2018
100
0.180
Why?
Enteral Nutrition
1
2018
136
0.180
Why?
Pulmonary Embolism
1
2019
172
0.170
Why?
Perception
1
2019
257
0.170
Why?
Thrombosis
1
2019
239
0.170
Why?
Adult
6
2020
30359
0.170
Why?
Incidence
2
2019
2317
0.160
Why?
Renal Replacement Therapy
1
2015
54
0.160
Why?
Adrenergic alpha-2 Receptor Agonists
1
2015
38
0.150
Why?
Placebo Effect
1
2015
48
0.150
Why?
Patient Discharge
1
2020
624
0.150
Why?
Young Adult
3
2019
10261
0.150
Why?
Diagnosis, Differential
1
2019
1433
0.150
Why?
Hospital Mortality
1
2019
775
0.150
Why?
Aged
5
2019
18934
0.140
Why?
Dose-Response Relationship, Drug
1
2019
2242
0.140
Why?
Randomized Controlled Trials as Topic
1
2018
1040
0.140
Why?
Aged, 80 and over
3
2019
6518
0.130
Why?
Hydrogen-Ion Concentration
1
2014
585
0.130
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
976
0.120
Why?
Double-Blind Method
1
2015
1609
0.110
Why?
Anti-Bacterial Agents
1
2019
1243
0.110
Why?
Treatment Outcome
3
2019
8608
0.100
Why?
Pharmacoepidemiology
2
2019
18
0.090
Why?
Severity of Illness Index
1
2015
2653
0.080
Why?
Neoplasms
1
2018
1913
0.080
Why?
Biomarkers
1
2015
3163
0.070
Why?
Adolescent
2
2019
17541
0.070
Why?
Antifungal Agents
1
2021
144
0.060
Why?
Hemostasis
1
2019
54
0.050
Why?
Comparative Effectiveness Research
1
2018
138
0.050
Why?
Academic Medical Centers
1
2019
396
0.040
Why?
Length of Stay
1
2019
984
0.040
Why?
Patient Readmission
1
2019
547
0.030
Why?
Databases, Factual
1
2018
1130
0.030
Why?
Clostridium Infections
1
2014
60
0.030
Why?
Propensity Score
1
2014
218
0.030
Why?
Animals
1
2014
34264
0.030
Why?
Quality of Life
1
2021
1817
0.030
Why?
Hospitalization
1
2019
1486
0.030
Why?
Pneumonia
1
2014
507
0.030
Why?
Colorado
1
2014
4483
0.020
Why?
United States
1
2018
11035
0.020
Why?
Reynolds's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)